Parallax Volatility Advisers, L.P. Fibrogen Inc Transaction History

Parallax Volatility Advisers, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $470,248 - $903,524	25,323 New	25,323 $674,000
Q2 2019 Aug 14, 2019	SELL	$35.13 - $55.53 $19,356 - $30,597	-551 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $23,599 - $33,010	551 New	551 $30,000
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $2.16 Million - $3.42 Million	-56,853 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$56.3 - $67.25 $508,501 - $607,402	-9,032 Reduced 13.71%	56,853 $3.45 Million
Q2 2018 Aug 14, 2018	BUY	$44.9 - $64.95 $2.96 Million - $4.28 Million	65,885 New	65,885 $4.12 Million
Q1 2018 May 15, 2018	SELL	$45.35 - $61.65 $481,889 - $655,092	-10,626 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$41.95 - $60.1 $445,760 - $638,622	10,626	10,626 $504,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.